Complutense University of Madrid, University of Santiago de Compostela patent DRD1 PAMs Jan. 16, 2019
City of Hope National Medical Center discovers poly(ADP-ribose) glycohydrolase inhibitors Jan. 15, 2019
New multitargeted PARP, PI3K and/or BRD4 inhibitors disclosed by SignalRx Pharmaceuticals Jan. 14, 2019
RSS